Sign inJoin waitlistJoin the waitlist

Miguel Cabada

Division Chief, Infectious Diseases · University of Texas Medical Branch Hospitals

Credentials: · · · · · ·

History

Infectious Diseases Division · University of Texas Medical Branch Hospitals
Present
University of Texas Medical Branch Hospitals
Present
University of Texas Medical Branch Hospitals
Present

Infectious Disease
University of Texas Medical Branch Hospitals
2009–2011
Texas Medical Branch
2000–2003
Graduate School of Biomedical Sciences from University of Texas Medical Branch
Texas Medical Branch
1996–2000

Research

Treatment of cryptosporidiosis: do we know what we think we know?
Review · Current Opinion in Infectious Diseases · 2010 · First of 2 authors · 100 citations
Human Fascioliasis: Current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control
Review · Research and Reports in Tropical Medicine · 2020 · 98 citations
Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis
Clinical Infectious Diseases · 2004 · 73 citations

Clinton White
29 papers
Melinda Tanabe
17 papers
Peter Melby
10 papers
MC
Mariale Caravedo
9 papers · 6 as a resident
Camille Webb-Camminati
5 papers · 4 as a fellow
David Walker
4 papers
Roberto Reyes
4 papers · 1 as a resident
DT
Drake Tilley
3 papers
Jill Weatherhead
3 papers
MP
Mary Perry
3 papers · 2 as a resident
Brittany Graham
2 papers · 1 as a resident
PH
Paige Hoyer
2 papers

Grants

A Non-Inferiority Randomized Single Blind Controlled Trial Comparing One and Two Dose Regimes of Oxfendazole Versus a Two Dose Regime of Triclabendazole to Treat Chronic Fascioliasis
National Institute of Allergy and Infectious Diseases · U01
PI · $2.1M · Universidad Peruana Cayetano Heredia
2023–2028
One-Health Approach to Study Human Fasciola Hepatica Transmission and Inform Strategic Control
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $2.4M · University of Texas Med Br Galveston
2022–2027
Markers of Triclabendazole Resistant Fascioliasis in the Highlands of Peru
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2M · University of Texas Med Br Galveston
2019–2025
Impact of Fascioliasis Among Children in the Peruvian Highlands
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $658.6K · Universidad Peruana Cayetano Heredia
2013–2018

Clinical trials

One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis
Study chair · Not yet recruiting · Phase 2
Universidad Peruana Cayetano Heredia
2026–2029